Up a level |
Kosiborod, Mikhail, Lam, Carolyn SP, Kohsaka, Shun, Kim, Dae Jung, Karasik, Avraham, Shaw, Jonathan, Tangri, Navdeep, Goh, Su-Yen, Thuresson, Marcus, Chen, Hungta et al (show 58 more authors)
(2018)
Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study.
Journal of the American College of Cardiology, 71 (23).
pp. 2628-2639.
Wilding, John ORCID: 0000-0003-2839-8404, Godec, Thomas, Khunti, Kamlesh, Pocock, Stuart, Fox, Robin, Smeeth, Liam, Clauson, Per, Fenici, Peter, Hammar, Niklas and Medina, Jesús
(2018)
Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink.
BMC Medicine, 16 (1).
116-.
Kosiborod, Mikhail, Birkeland, Kare I, Cavender, Matthew A, Fu, Alex Z, Wilding, John P ORCID: 0000-0003-2839-8404, Khunti, Kamlesh, Holl, Reinhard W, Norhammar, Anna, Jorgensen, Marit E, Wittbrodt, Eric T et al (show 4 more authors)
(2018)
Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study.
DIABETES OBESITY & METABOLISM, 20 (8).
pp. 1983-1987.
Kosiborod, Mikhail, Cavender, Matthew A, Fu, Alex Z, Wilding, John P ORCID: 0000-0003-2839-8404, Khunti, Kamlesh, Holl, Reinhard W, Norhammar, Anna, Birkeland, Kare I, Jorgensen, Marit Eika, Thuresson, Marcus et al (show 4 more authors)
(2018)
Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)".
CIRCULATION, 137 (9).
pp. 989-991.
Cavender, Matthew A, Norhammar, Anna, Birkeland, Kare I, Jorgensen, Marit Eika, Wilding, John P ORCID: 0000-0003-2839-8404, Khunti, Kamlesh, Fu, Alex Z, Bodegard, Johan, Blak, Betina T, Wittbrodt, Eric et al (show 4 more authors)
(2018)
SGLT-2 Inhibitors and Cardiovascular Risk An Analysis of CVD-REAL.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 71 (22).
pp. 2497-2506.